Disruption of muscle architecture and myocardial degeneration in mice lacking desmin

Journal of Cell Biology

Volumn 134, Issue 5, 1996, Pages 1255-1270

  Milner, Derek J ^a   Weitzer, Georg ^a,b   Tran, Duyen ^a   Bradley, Allan ^a   Capetanaki, Yassemi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HYPOPLASIA; INTESTINE MUSCLE; MOUSE; MUSCLE ATROPHY; MUSCLE FIBRIL; MUSCLE MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALIA;

EID: 0029738727     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.134.5.1255     Document Type: Article

References (99)

1. Allen, R.E., L.L. Rankin, E.A. Greene, L.K. Boxhorn, S.E. Johnson, R.G. Taylor, and P.A. Pierce. 1991. Desmin is present in proliferating rat muscle satellite cells hut not in bovine muscle satellite cells. J. Cell Physiol. 149:525-535.
2. Arnold, H.H., and T. Braun. 1993. The role of Myf5 in somitogenesis and the development of skeletal muscles in vertebrates. J. Cell Sci. 104:957-960.
3. Ariza, A., J. Coll, M.T. Fernandez-Figueras, M.D. Lopez, J.L. Mate, O. Garcia, A. Fernandez-Vasalo, and J.J. Navas-Palacios. 1995. Desmin myopathy: a multisystem disorder involving skeletal, cardiac and smooth muscle. Human Pathol. 26:1032-1037.
4. Becker, B., R.M. Bellin, S.W. Sernett, T.W. Huiatt, and R.M. Robson. 1995. Synemin contains the rod domain of intermediate filaments. Biochem. Biophys. Res. Commun. 213:796-802.
5. Bennett, G.S., S.A. Fellini, Y. Toyama, and H. Holtzer. 1979. Redistribution of intermediate filament subunits during skeletal myogenesis and maturation in vitro. J. Cell Biol. 82:577-584.
6. Bonifas, J.M., A.L. Rothman, and E.H. Epstein. 1991. Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science (Wash. DC). 254:1202-1205.
7. Capetanaki, Y., J. Ngai, and E. Lazarides. 1984a. Characterization and regulation in the expression of a gene encoding for the intermediate filament protein desmin. Proc. Natl. Acad. Sci. USA. 81:6909-6912.
8. Capetanaki, Y., J. Ngai, and E Lazarides. 1984b. Regulation of the expression of the genes coding for the intermediate filament subunits vimentin, desmin and glial fibrillary acidic protein. In Molecular Biology of the Cytoskeleton. G. Borisy et al., editors. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
9. Capetanaki, Y., S. Smith, and J.P. Heath. 1989. Overexpression of the vimentin gene in transgenic mice inhibits normal lens cell differentiation. J. Cell Biol. 109:1653-1664.
10. Cary, R.B., and M.W. Klymkowsky. 1995. Disruption of intermediate filament organization leads to structural defects at the intersomite junction in Xenopus myotomal muscle. Development. 121:1041-1052.
11. Chan Y.-M., Q.-C. Yu., A. Christiano, J. Uitto, R.S. Kucherlapati, J. LeBlanc-Straceski, and E. Fuchs. 1994. Mutations in the non-helical linker segment L1-2 of keratin 5 in patients with Weber-Cockayne epidermolysis bullosa simplex. J. Cell Sci. 107:765-774.
12. Cheng, J., A.J. Snyder, Q.C. Yu, A. Letai, A.S. Paller, and E. Fuchs. 1992. The genetic basis of of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell. 70:811-819.
13. Chipev, C.C., B.P. Korge, N. Markova, S.J. Bale, J.J. DiGiovanna, J.G. Compton, and P.M. Steinert. 1992. A leucine to proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell. 70:821-828.
14. Choi, J., M.L. Costa, C.S. Mermelstein, C. Chagas, S. Holtzer, and H. Holtzer. 1990. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle and retinal pigmented epithelial cells into striated mononucleated and multinucleated myotubes. Proc. Natl. Acad. Sci. USA. 87:7988-7992.
15. Collard, J.F., F. Cote, and J.P. Julien. 1995. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature (Lond.). 375:61-64.
16. Colucci-Guyon, E., M.-M. Portier, I. Dunia, D. Paulin, S. Pournin, and C. Babinet. 1994. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell. 79:579-694.
17. Cote, F., J. Collard, and J. Julien. 1993. Progressive neuropathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model for amyotrophic lateral sclerosis. Cell. 73:35-46.
18. Coulombe, P.A., M.E. Hutton, A. Letai, A. Herbert, S.A. Paller, and E. Fuchs. 1991a. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell. 66:1301-1311.
19. Coulombe, P.A., M.E. Hutton, R. Vassar, and E. Fuchs. 1991b. A function for keratins and a common thread among different types of epidermolysis bullosa simplex disease. J. Cell Biol. 115:1661-1674.
20. Danto, S.I., and D.A. Fischman. 1984. Immunocytochemical analysis of intermediate filaments in embryonic heart cells with monoclonal antibodies to desmin. J. Cell Biol. 98:2179-2191.
21. Dunia, I., F. Pieper, S. Manenti, A. van de Kamp, G. Devilliers, E.L. Benedetti, and H. Bloemendal. 1990. Plasma membrane-cytoskeleton damage in eye lenses of transgenic mice expressing desmin. Eur. J. Cell Biol. 53:59-74.
22. Evans, R.M. 1994. Intermediate filaments and lipoprotein cholesterol. Trends Cell Biol. 4:149-151.
23. Forgacs, G. 1995. On the possible role of cytoskeletal filamentous networks in intracellular signalling: an approach based on percolation. J. Cell Sci. 108: 2131-2143.
24. Fuchs, E. 1994. Intermediate filaments and disease: mutations that cripple cell strength. J. Cell Biol. 125:511-516.
25. Fuchs, E., and K. Weber. 1994. Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 63:345-382.
26. Gard, D.L., and H. Lazarides. 1980. The synthesis and distribution of desmin and vimentin during myogenesis in vitro. Cell. 19:263-275.
27. Georgatos, S.D., and C. Maison. 1996. Integration of intermediate filaments into cellular organelles. Int. Rev. Cytol. 164:91-138.
28. Goebel, H., and A. Bornemann. 1993. Desmin pathology in neuromuscular disease. Virchows Archiv. B Cell Pathol. 64:127-135.
29. Gomi, H., T. Yokoyama, K. Fujimoto, T. Ikeda, A. Katoh, T. Itoh, and S. Itohara. 1995. Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron. 14:29-41.
30. Granger, B.L., and E. Lazarides. 1978. The existence of an insoluble z-disc scaffold in chicken skeletal muscle. Cell. 15:1253-1268.
31. Granger, B.L., and E. Lazarides. 1979. Desmin and vimentin exist at the periphery of the z-disc. Cell. 18:1053-1063.
32. Granger, B.L., and H. Lazarides 1980. Synemin: a new high molecular weight protein associated with desmin and vimentin filaments in muscle. Cell. 22: 727-38.
33. Grounds, M.D., and Z. Yablonka-Reuveni. 1993. Molecular and cell biology of skeletal muscle regeneration. In Molecular and Cell Biology of Muscular Dystrophy. T. Partridge, editor. Chapman and Hall, London, pp. 210-256.
34. Guo, L., L. Degenstein, J. Dowling, Q.-C. Yu, R. Wollmann, B. Perman, and E. Fuchs. 1995. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell. 81:233-243.
35. Herrmann, H., B. Fouquet, and W.W. Franke. 1989. Expression of intermediate filament proteins during development of Xenopus laevis. II. Identification and molecular characterization of desmin. Development. 105:299-307.
36. Hill, C.S., S. Duran, and Z.X. Lin. 1986. Titin and myosin, but not desmin, are linked during myofibrillogenesis in postmitotic mononucleated myoblasts. J. Cell Biol. 103:2185-2196.
37. Holtzer, H., G.S. Bennett, S.J. Tapscott, J.N. Croop, and Y. Toyawa. 1982. Intermediate sized filaments: changes in synthesis and distribution in cells of myogenic and neurogenic lineages. Cold Spring Harbor Symp. Quat. Biol. 46:317-329.
38. Horowitz, S.H., and H. Schmalbruch. 1994. Autosomal dominant distal myopathy with desmin storage: a clinicopathologic and electrophysiologic study of a large kinship. Muscle & Nerve. 17:151-160.
39. Ingber, D.E. 1993. The riddle of morphogenesis: a question of solution chemistry or molecular cell engineering? Cell. 75:1249-1252.
40. Ishikawa, H., R. Bischoff, and H. Holtzer. 1968. Mitosis and intermediate-sized filaments in developing skeletal muscle. J. Cell Biol. 38:538-555.
41. Jackson, M.J. 1993. Molecular mechanisms of muscle damage. In Molecular and Cell Biology of Muscular Dystrophy. T. Partridge, editor. Chapman and Hall, London, pp. 257-282.
42. Kachinsky, A.M., J.A. Dominov, and J.B. Miller. 1994. Myogenesis and the intermediate filament protein, nestin. Dev. Biol. 165:216-228.
43. Kachinsky, A.M., J.A. Dominov, and J.B. Miller. 1995. Intermediate filaments in cardiac myogenesis: nestin in the developing mouse heart. J. Histochem. Cytochem. 43:843-847.
44. Kaufman, S.J., and R. Foster. 1988. Replicating myoblasts express a muscle-specific phenotype. Proc. Natl. Acad. Sci. USA. 85:9606-9610.
45. Klymkowsky, M. 1995. Intermediate filaments: new proteins, some answers, more questions. Curr. Opin. Cell Biol. 7:46-54.
46. Kuisk, I.R., H. Li, D. Tran, and Y. Capetanaki. 1996. A single MEF2 site governs desmin transcription in both heart and skeletal muscle during mouse embryogenesis. Dev. Biol. 174:1-13.
47. Lane, E.B., E.L. Rugg, H.J. Navsaria, I.M. Leigh, A.H.M. Heagerty, A. Ishida-Yamamoto and R.A.J. Eady. 1992. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature (Lond.). 356: 244-246.
48. Lazarides, F., and B.D. Hubbard. 1976. Immunological characterization of the subunit of the 100Å filaments from muscle cells. Proc. Natl. Acad. Sci. USA. 73:4344-4348.
49. Lazarides, E. 1980. Intermediate filaments as mechanical integrators of cellular space. Nature (Lond.). 238:249-256.
50. Lazarides, E., and Y. Capetanaki. 1986. The striated muscle cytoskeleton: expression and assembly in development. Molecular Biology of Muscle Development. 749-772.
51. Lee, M.K., and D.W. Cleveland. 1994. Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease. Curr. Opin. Cell Biol. 6: 34-40.
52. Li, H., and Y. Capetanaki. 1993. Regulation of the mouse desmin gene: transactivation by MyoD, myogenin MRF4 and Myf5. Nucleic Acids Res. 21:335-343.
53. Li, H., and Y. Capetanaki. 1994. An E box in the desmin promoter cooperates with the E box and MEF2 sites of a distal enhancer to direct muscle-specific transcription. EMBO (Eur. Mol. Biol. Organ.) J. 13:3580-3589.
54. Li, H., S.K. Choudhary, D.J. Milner, M.I. Munir, I.R. Kuisk, and Y. Capetanaki. 1994. Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators myoD and myogenin. J. Cell Biol. 124: 827-841.
55. Li, Z., E. Colucci-Guyon, M. Pincon-Raymond, M. Merieskay, S. Pournin, D. Paulin, and C. Babinet. 1996. Cardiac lesions and skeletal myopathy in mice lacking desmin. Dev. Biol. 175:362-366.
56. Lin, Z., M.-H. Lu, T. Schultheiss, J. Choi, S. Holtzer, C. DiLullo, D.A. Fischman, and H. Holtzer. 1994. Sequential appearance of muscle-specific proteins in myoblasts as a function of time after cell division: evidence for a conserved myoblast differentiation program in skeletal muscle. Cell Motil. Cytoskeleton. 29:1-19.
57. Lloyd, C., Q.-C. Yu, J. Cheng, K. Turksen, L. Degenstein, E. Hutton, and E. Fuchs. 1995. The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J. Cell Biol. 129:1329-1344.
58. Lockhardt, V.G., and S. Bloom. 1993. Trans-cellular desmin-lamin B intermediate filament network in cardiac myocytes. J. Mol. Cell. Cardiol. 25:303-309.
59. Lyons, G.E., and M.E. Buckingham. 1992. Developmental regulation of myogenesis in the mouse. Semin. Dev. Biol. 3:2443-2453.
60. Lyons, G.E., and M.E. Buckingham. 1993. Myogenic factor gene expression in mouse somites and limb buds. Mol. Basis Morphogen. 155-164.
61. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY. pp. 382-389.
62. Mayo, M.L., P. Bringas, Jr., V. Santos, L. Shum, and H.C. Slavkin. 1992. Desmin expression during early mouse tongue morphogenesis. Int. J. Dev. Biol. 36:255-263.
63. McLean, W.H.I., and E.B. Lane. 1995. Intermediate filaments in disease. Curr. Opin. Cell Biol. 7:118-125.
64. Muguruma, M., K. Kobayashi, T. Fukazawa, and K. Ohashi. 1981. A new 220,000 dalton protein located in the z lines of vertebrate skeletal muscle. J. Biochem. 89:1981-1984.
65. Nelson, W.I., and E. Lazarides. 1984. Globin(ankyrin) in striated muscle: identification of the potential membrane recepter for erythroid spectrin in muscle cells. Proc. Natl. Acad. Sci. USA. 81:3292-3296.
66. Olson, E.N., and Y. Capetanaki. 1989. Developmental regulation of intermediate filaments and actin mRNA during myogenesis is disrupted by oncogenic ras genes. Oncogene. 4:907-913.
67. Olson, E.N., and W.H. Klein. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
68. Porter, R.M., S. Leitgeb, D.W. Melton, O. Swensson, R.A.J. Eady, and T.M. Magin. 1996. Gene targeting of the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis. J. Cell Biol. 132:925-936.
69. Price, M.G., and E. Lazarides. 1983. Expression of the intermediate filament-associated proteins paranemin and synemin in chicken development. J. Cell Biol. 97:1860-1874.
70. Price, M.G. 1992 Striated muscle endosarcomeric and exosarcomeric lattices. Adv. Struct. Biol. 1:175-207.
71. Reis, A., H.-C. Hennes, L. Langbein, M. Digweed, D. Mischke, M. Drechsler, E. Schrock, B. Royker-Pokora, W.W. Franke, K. Sperling, et al. 1994. Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPKK). Nature Genet. 6:174-179.
72. Richardson, F.L., M.H. Stromer, T.W. Huiatt, and R.M. Robson. 1981. Immunoelectron and immunofluorescence localization of desmin in mature avian muscle. Eur. J. Cell Biol. 26:91-101.
73. Robertson, E.J., editor. 1987. Teratocarcinomas and Embryonic Stem Cells: a Practical Approach. IRL Press, Oxford, 113-181.
74. Rothnagel, J.A., A.M. Dominey, L.D. Dempsey, M.A. Longley, D.A. Greenhalgh, T.A. Gagne, M. Huber, E. Frenk, D. Hohl, and D.R. Roop. 1992. Mutations in the rod domins of keratins 1 and 10 in epidermolytic hyperkeratosis. Science (Wash. DC). 257:1128-1130.
75. Rugg, E.L., W.H.I. McLean, E.B. Lane, R. Pitera, J.R. McMillan, P.J.C. Dopping-Hepenstal, H.A. Navsaria, I.M. Leigh, and R.A.J. Eady. 1994. A functional "knock-out" for human keratin 14. Genes Dev. 8:2563-2573.
76. Sassoon, D.A. 1993. Myogenic regulatory factors: dissecting their role and regulation during vertebrate embryogenesis. Dev. Biol. 156:11-23.
77. Schaart, G., C. Viebahn, W. Langmann, and F. Raemakers. 1989. Desmin and titin expression in early post-implantation mouse embryos. Development. 107:581-616.
78. Schmid, E., M. Osborn, E. Rungger-Brandle, G. Gabbiani, K. Weber, and W.W. Franke. 1982. Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta. Exp. Cell Res. 137: 329-340.
79. Schultheiss, T., Z. Lin, H. Ishikawa, I. Zamir, C.J. Stocckert, and H. Holtzer. 1991. Desmin/vimentin intermediate filaments are dispensible for many aspects of myogenesis J. Cell Biol. 114:953-966
80. Sejernsen, T., and U. Lendahl. 1993. Transient expression of the intermediate filament nestin during skeletal muscle development. J. Cell Sci. 106:1291-1300.
81. Shibuki, K., H. Gomi, L. Chen, S. Bao, J.J. Kim, H. Wakatsuki, T. Fujisaki, K. Fujimoto, A. Katoh, T. Ikeda, et al. 1996. Deficient cerebellar long-term depression, impaired eyeblink conditioning and normal motor coordination in GFAP mutant mice. Neuron. 16:587-599.
82. Small, J.V., D.O. Furst, and L.-E. Thornell. 1992. The cytoskeletal lattice of muscle cells. Eur. J. Biochem. 208:559-572.
83. Smith, T.H., A.M. Kachinsky, and J.B. Miller. 1994. Somite subdomains, muscle cell origins and the four muscle regulatory proteins. J. Cell Biol. 127:95-105.
84. Steinert, P.M., and D.R. Roop. 1988. Molecular and cellular biology of intermediate filaments. Annu. Rev. Biochem. 57:593-625.
85. Tao J.-X., and W. Ip. 1991. Site-specific antibodies block kinase A phosphorylation of desmin in vitro and inhibit incorporation of myoblasts into myotubes. Cell Motil. Cytoskeleton. 19:109-120.
86. Thomas, K.R., and M.R. Capecchi. 1987. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51:503-512.
87. Thornell, L.E., L. Edstrom, A. Eriksson, K.G. Henriksson, and K.A. Angqvist. 1980. The distribution of intermediate filament protein (skeletin) in normal and diseased skeletal muscle. An immunohistochemical and electron microscopic study. J. Neurol. Sci. 47:153-170.
88. Thornell, L.E., A. Eriksson, and L. Erdstom. 1983. Intermediate filaments in human myopathies. In Cell and Muscle Motility. R.B. Dowben, and J.W. Shay, editors. Plenum Publishing, New York. pp. 85-135.
89. Thornell, L.E., A. Eriksson, B. Johansson, and U. Kjorell. 1985. Intermediate filaments and associated proteins in heart Purkinje fibers: a membrane-myofibril anchored cytoskeletal system. Ann. N.Y. Acad. Sci. 455:213-224.
90. Tokuyasu, K.T., A.H. Dutton, and S.J. Singer. 1983a. Immunoelectron microscopic studies of desmin (skeletin) localization and intermediate filament organization in chicken skeletal muscle J. Cell Biol. 96:1727-1735.
91. Tokuyasu, K.T., A.H. Dutton, and S.J. Singer. 1983b. Immunoelectron microscopic studies of desmin (skeletin) localization and intermediate filament organization in chicken cardiac muscle J. Cell Biol. 96:1736-1742.
92. Tokuyasu, K.T., P.A. Maher, and S.J. Singer. 1984. Distributions of vimentin and desmin in developing chick myotubes in vivo. 1. Immunofluorescence study. J. Cell Biol. 98:1961-1972.
93. Torchard, D. 1994. Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nat. Genet. 6:106-110.
94. Traub, P., and R.L. Shoeman 1994. Intermediate filament proteins: cytoskeletal elements with gene-regulatory function. Int. Rev. Cytol. 154:1-101.
95. Vassar, R., P.A. Coulombe, L. Degenstein, K. Albers, and E. Fuchs. 1991. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell. 64:365-380.
96. Vajsar, J., L. E. Becker, R.M. Freedom, and E.G. Murphy. 1993. Familial desminopathy: myopathy with accumulation of desmin-type intermediate filaments. J. Neurol. Neurosurg. Psychiatry. 56:644-648.
97. Wang, N., J.P. Butler, and D.E. Ingber. 1993 Mechanotransduction across the cell surface and through the cytoskeleton. Science (Wash. DC). 260:1124-1127.
98. Weitzer, G., D.J. Milner, J.-U. Kim, A. Bradley, and Y. Capetanaki. 1995. Cytoskeletal control of myogenesis: a desmin null mutation blocks the myogenic pathway during embryonic stem cell differentiation. Dev. Biol. 172: 422-439.
99. Xu, Z., L. Cork, J. Griffin, and D.W. Cleveland. 1993. Increased expression of neurofilament NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 73:23-33.